Satellos Bioscience Inc
TSX:MSCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Satellos Bioscience Inc
TSX:MSCL
|
CA |
|
SalMar ASA
OSE:SALM
|
NO |
|
Trevi Therapeutics Inc
NASDAQ:TRVI
|
US |
|
A
|
American Electric Power Company Inc
F:AEP
|
US |
|
Canandaigua National Corp
OTC:CNND
|
US |
|
H
|
Hyflux Ltd
SGX:600
|
SG |
|
Ceapro Inc
XTSX:CZO
|
CA |
Wall St Price Targets
MSCL Price Targets Summary
Satellos Bioscience Inc
According to Wall Street analysts, the average 1-year price target for MSCL is 23.87 CAD with a low forecast of 11.11 CAD and a high forecast of 42 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MSCL's stock price target?
Price Target
23.87
CAD
According to Wall Street analysts, the average 1-year price target for MSCL is 23.87 CAD with a low forecast of 11.11 CAD and a high forecast of 42 CAD.